La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Galenica Résultats passés
Passé contrôle des critères 4/6
Galenica has been growing earnings at an average annual rate of 3.1%, while the Healthcare industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 3% per year. Galenica's return on equity is 12.1%, and it has net margins of 4.5%.
Informations clés
3.1%
Taux de croissance des bénéfices
2.8%
Taux de croissance du BPA
| Healthcare Croissance de l'industrie | 13.4% |
| Taux de croissance des recettes | 3.0% |
| Rendement des fonds propres | 12.1% |
| Marge nette | 4.5% |
| Prochaine mise à jour des résultats | 11 Mar 2025 |
Mises à jour récentes des performances passées
Recent updates
Earnings Not Telling The Story For Galenica AG (VTX:GALE)
Jul 31
Is Galenica (VTX:GALE) Using Too Much Debt?
Jun 16Galenica AG (VTX:GALE) Investors Are Less Pessimistic Than Expected
Apr 25We Think The Compensation For Galenica AG's (VTX:GALE) CEO Looks About Right
Apr 04Slowing Rates Of Return At Galenica (VTX:GALE) Leave Little Room For Excitement
Mar 29Pinning Down Galenica AG's (VTX:GALE) P/E Is Difficult Right Now
Jan 22Is There An Opportunity With Galenica AG's (VTX:GALE) 42% Undervaluation?
Jan 04Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes
Oct 26Is Galenica (VTX:GALE) Using Too Much Debt?
Oct 11Are Investors Undervaluing Galenica AG (VTX:GALE) By 42%?
Sep 26These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well
Jun 20Here's What To Make Of Galenica's (VTX:GALE) Decelerating Rates Of Return
Apr 17We Think Galenica (VTX:GALE) Can Stay On Top Of Its Debt
Mar 12Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes
Jan 08These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well
Nov 28The Returns At Galenica (VTX:GALE) Aren't Growing
Sep 20Is Galenica (VTX:GALE) A Risky Investment?
Aug 30Return Trends At Galenica (VTX:GALE) Aren't Appealing
Jun 15Galenica (VTX:GALE) Could Easily Take On More Debt
Apr 06Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward
Feb 15Should You Be Adding Galenica (VTX:GALE) To Your Watchlist Today?
Jan 02Does Galenica (VTX:GALE) Have A Healthy Balance Sheet?
Nov 30Returns At Galenica (VTX:GALE) Appear To Be Weighed Down
Oct 24With EPS Growth And More, Galenica (VTX:GALE) Is Interesting
Sep 25Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Aug 24Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward
Jul 24If You Like EPS Growth Then Check Out Galenica (VTX:GALE) Before It's Too Late
Jun 12Investors Met With Slowing Returns on Capital At Galenica (VTX:GALE)
Apr 07Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Mar 25Galenica AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Mar 11Is Galenica AG (VTX:GALE) The Right Choice For A Smart Dividend Investor?
Feb 27Are Institutions Heavily Invested In Galenica AG's (VTX:GALE) Shares?
Jan 31
Galenica (VTX:GALE) Shareholders Have Enjoyed A 25% Share Price Gain
Jan 13Is Galenica (VTX:GALE) Likely To Turn Things Around?
Dec 25Is Galenica (VTX:GALE) A Risky Investment?
Dec 09Is Galenica AG (VTX:GALE) An Attractive Dividend Stock?
Nov 24Ventilation des recettes et des dépenses
Comment Galenica gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 3,803 | 170 | 5 | 0 |
| 31 Mar 24 | 3,780 | 167 | 5 | 0 |
| 31 Dec 23 | 3,756 | 165 | 5 | 0 |
| 30 Sep 23 | 3,724 | 158 | 5 | 0 |
| 30 Jun 23 | 3,693 | 152 | 5 | 0 |
| 31 Mar 23 | 3,644 | 154 | 5 | 0 |
| 31 Dec 22 | 3,595 | 157 | 5 | 0 |
| 30 Sep 22 | 3,671 | 162 | 5 | 0 |
| 30 Jun 22 | 3,746 | 167 | 5 | 0 |
| 31 Mar 22 | 3,794 | 167 | 5 | 0 |
| 31 Dec 21 | 3,841 | 168 | 5 | 0 |
| 30 Sep 21 | 3,746 | 177 | 5 | 0 |
| 30 Jun 21 | 3,652 | 185 | 5 | 0 |
| 31 Mar 21 | 3,568 | 179 | 5 | 0 |
| 31 Dec 20 | 3,485 | 172 | 5 | 0 |
| 30 Sep 20 | 3,441 | 149 | 5 | 0 |
| 30 Jun 20 | 3,396 | 126 | 6 | 0 |
| 31 Mar 20 | 3,351 | 126 | 6 | 0 |
| 31 Dec 19 | 3,306 | 125 | 6 | 0 |
| 30 Sep 19 | 3,256 | 140 | 32 | 0 |
| 30 Jun 19 | 3,206 | 156 | 58 | 0 |
| 31 Mar 19 | 3,188 | 152 | 58 | 0 |
| 31 Dec 18 | 3,171 | 148 | 58 | 0 |
| 30 Sep 18 | 3,165 | 132 | 57 | 0 |
| 30 Jun 18 | 3,159 | 117 | 56 | 0 |
| 31 Mar 18 | 3,152 | 118 | 56 | 0 |
| 31 Dec 17 | 3,145 | 119 | 56 | 0 |
| 30 Sep 17 | 3,112 | 111 | 56 | 0 |
| 30 Jun 17 | 3,078 | 104 | 56 | 0 |
| 31 Mar 17 | 3,057 | 94 | 56 | 0 |
| 31 Dec 16 | 3,037 | 83 | 56 | 0 |
| 31 Dec 15 | 2,918 | 81 | 55 | 0 |
| 31 Dec 14 | 2,829 | 82 | 55 | 0 |
Des revenus de qualité: GALE has high quality earnings.
Augmentation de la marge bénéficiaire: GALE's current net profit margins (4.5%) are higher than last year (4.1%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: GALE's earnings have grown by 3.1% per year over the past 5 years.
Accélération de la croissance: GALE's earnings growth over the past year (11.6%) exceeds its 5-year average (3.1% per year).
Bénéfices par rapport au secteur d'activité: La croissance des bénéfices GALE au cours de l'année écoulée ( 11.6% ) n'a pas surpassé celle du secteur Healthcare 15.5%.
Rendement des fonds propres
ROE élevé: GALE's Return on Equity (12.1%) is considered low.